The treatment of dermatological infections with a manganese phenanthroline chelate. A controlled clinical trial.
D000085:Acetates / Q000627:therapeutic use; D003883:Arthrodermataceae / Q000187:drug effects / Q000302:isolation & purification; D001414:Bacitracin / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D006801:Humans; D008345:Manganese / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009262:Nails / Q000382:microbiology; D009355:Neomycin / Q000627:therapeutic use; D010618:Phenanthrolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012457:Salicylamides / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013431:Sulfates / Q000627:therapeutic use
D000085:Acetates; D010618:Phenanthrolines; D011113:Polymyxins; D011804:Quinolines; D012457:Salicylamides; D012459:Salicylates; D013431:Sulfates; D001414:Bacitracin; D008345:Manganese; D009355:Neomycin